Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wesam Shamseldin Shalaby

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Oman Journal of Ophthalmology|June 4, 2021
Neovascularization of angle following trabeculectomy augmented with mitomycin-CWesam Shamseldin Shalaby, Reza Razeghinejad
Medical Gas Research|January 20, 2025
Latanoprostene bunod: the first nitric oxide-donating antiglaucoma medicationGhazaleh Soltani, Wesam Shamseldin Shalaby, Reza Razeghinejad
Clinical & Experimental Optometry|August 17, 2021
Systemic side effects of glaucoma medicationsAmirmohsen Arbabi, Xuan Bao, Wesam Shamseldin Shalaby, et al.
Journal of Cataract and Refractive Surgery|August 26, 2020
iStent inject: comprehensive reviewWesam Shamseldin Shalaby, Jing Jia, L Jay Katz, et al.
Journal of Ophthalmic & Vision Research|April 19, 2024
Contemporary Approach to Narrow AnglesWesam Shamseldin Shalaby, Rohit Reddy, Reza Razeghinejad, et al.
Expert Opinion on Pharmacotherapy|July 28, 2020
Current and new pharmacotherapeutic approaches for glaucomaWesam Shamseldin Shalaby, Vikram Shankar, Reza Razeghinejad, et al.
Survey of Ophthalmology|December 10, 2021
A review of potential novel glaucoma therapeutic options independent of intraocular pressureWesam Shamseldin Shalaby, Osama M Ahmed, Michael Waisbourd, et al.
Current Ophthalmology Reports|July 11, 2025
Systemic Carbonic Anhydrase Inhibitors in Common Ophthalmic Diseases: A Scoping Review from A Clinical StandpointShahin Hallaj, Wesam Shamseldin Shalaby, Sapna Sinha, et al.
Journal of Glaucoma|July 31, 2023
Persistent Mydriasis Following Gonioscopy-Assisted Transluminal TrabeculotomyShahin Hallaj, Jae-Chiang Wong, Wesam Shamseldin Shalaby, et al.
Ocular Immunology and Inflammation|March 4, 2025
Risk Factors for Progression of Graft Rejection to Graft Failure Following Penetrating KeratoplastyWesam Shamseldin Shalaby, Eric J Shiuey, Tejal M Patel, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Oman Journal of Ophthalmology|June 4, 2021
Neovascularization of angle following trabeculectomy augmented with mitomycin-CWesam Shamseldin Shalaby, Reza Razeghinejad
Medical Gas Research|January 20, 2025
Latanoprostene bunod: the first nitric oxide-donating antiglaucoma medicationGhazaleh Soltani, Wesam Shamseldin Shalaby, Reza Razeghinejad
Clinical & Experimental Optometry|August 17, 2021
Systemic side effects of glaucoma medicationsAmirmohsen Arbabi, Xuan Bao, Wesam Shamseldin Shalaby, et al.
Journal of Cataract and Refractive Surgery|August 26, 2020
iStent inject: comprehensive reviewWesam Shamseldin Shalaby, Jing Jia, L Jay Katz, et al.
Journal of Ophthalmic & Vision Research|April 19, 2024
Contemporary Approach to Narrow AnglesWesam Shamseldin Shalaby, Rohit Reddy, Reza Razeghinejad, et al.
Expert Opinion on Pharmacotherapy|July 28, 2020
Current and new pharmacotherapeutic approaches for glaucomaWesam Shamseldin Shalaby, Vikram Shankar, Reza Razeghinejad, et al.
Survey of Ophthalmology|December 10, 2021
A review of potential novel glaucoma therapeutic options independent of intraocular pressureWesam Shamseldin Shalaby, Osama M Ahmed, Michael Waisbourd, et al.
Current Ophthalmology Reports|July 11, 2025
Systemic Carbonic Anhydrase Inhibitors in Common Ophthalmic Diseases: A Scoping Review from A Clinical StandpointShahin Hallaj, Wesam Shamseldin Shalaby, Sapna Sinha, et al.
Journal of Glaucoma|July 31, 2023
Persistent Mydriasis Following Gonioscopy-Assisted Transluminal TrabeculotomyShahin Hallaj, Jae-Chiang Wong, Wesam Shamseldin Shalaby, et al.
Ocular Immunology and Inflammation|March 4, 2025
Risk Factors for Progression of Graft Rejection to Graft Failure Following Penetrating KeratoplastyWesam Shamseldin Shalaby, Eric J Shiuey, Tejal M Patel, et al.
Pageof 3